Literature DB >> 32563756

'Small communities, large oversight': The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada.

Cayley Russell1, Sameer Imtiaz2, Farihah Ali2, Tara Elton-Marshall3, Jürgen Rehm4.   

Abstract

The opioid epidemic continues to exert a large toll on public health across Canada, with the province of Ontario specifically experiencing exceptionally high opioid-related hospitalizations and overdoses in 2019. As a key evidence-based public health intervention to reduce these harms, over the past few years supervised consumption services (SCS), including temporary and flexible unsanctioned models, have been implemented in select cities across the province. However, in March 2019, the newly elected Ontario provincial government replaced SCS regulations with a 'streamlined' model that introduced additional bureaucratic and administrative requirements for application approval and funding, while placing a cap on the number of sites allowed. Only a select few sites were approved, despite the ability of numerous cities across the province to demonstrate a need for SCS in their community. Importantly, many small communities throughout Ontario have been experiencing opioid-related harms at rates which far outpace those of larger cities. Several of these communities have been actively working towards securing SCS sites, but have been unable to do so as they do not have the resources to meet stringent application requirements. These regulatory changes therefore hinder the feasibility of small communities to implement necessary and life-saving SCS, which will affect lives. This is a major oversight.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canada; Communities; Consumption and treatment services; Harm reduction; Ontario; Opioids; Overdose prevention; Policy; Public health; Supervised consumption services

Mesh:

Substances:

Year:  2020        PMID: 32563756     DOI: 10.1016/j.drugpo.2020.102822

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  6 in total

1.  Using conjoint analysis to study health policy changes: An example from a cohort of persons who use drugs.

Authors:  Hannah K Knudsen; Jennifer R Havens
Journal:  Int J Drug Policy       Date:  2021-08-26

2.  The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada.

Authors:  Geoff Bardwell; Leslie Lappalainen
Journal:  Can J Public Health       Date:  2021-03-29

3.  Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19.

Authors:  Michelle Olding; Allison Barker; Ryan McNeil; Jade Boyd
Journal:  Int J Drug Policy       Date:  2020-12-10

4.  A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.

Authors:  Cayley Russell; Farihah Ali; Frishta Nafeh; Sean LeBlanc; Sameer Imtiaz; Tara Elton-Marshall; Jürgen Rehm
Journal:  BMC Public Health       Date:  2021-11-06       Impact factor: 3.295

5.  Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.

Authors:  Annie Foreman-Mackey; Bernie Pauly; Andrew Ivsins; Karen Urbanoski; Manal Mansoor; Geoff Bardwell
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-10-08

Review 6.  To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.

Authors:  Kelsey A Speed; Nicole D Gehring; Katherine Launier; Daniel O'Brien; Sandy Campbell; Elaine Hyshka
Journal:  Harm Reduct J       Date:  2020-10-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.